Increase in Global Cancer Incidence, Drop in Death Rates

Share this content:
Increase in Global Cancer Incidence, Drop in Death Rates
Increase in Global Cancer Incidence, Drop in Death Rates

TUESDAY, June 12, 2018 (HealthDay News) -- Worldwide, cancer cases increased by 28 percent from 2006 to 2016, according to a study published online June 2 in JAMA Oncology.

Christina Fitzmaurice, M.D., M.P.H., from the University of Washington in Seattle, and colleagues examined the burden for 29 cancer groups over time. The Global Burden of Disease study estimation methods were used to assess cancer incidence, mortality, years lived with disability, years of life lost, and disability-adjusted life years (DALYs) for 195 countries and territories.

The researchers found that there were 17.2 million cancer cases worldwide and 8.9 million deaths in 2016. Between 2006 and 2016, there was a 28 percent increase in cancer cases. High Sociodemographic Index countries had the smallest increase. Population aging, population growth, and changes in age-specific rates contributed 17, 12, and −1 percent to this change globally, respectively. For men, the most common incident cancer globally was prostate cancer, while the leading cause of cancer deaths and DALYs was tracheal, bronchus, and lung cancer. For women, breast cancer was the most common incident cancer and the leading cause of cancer death and DALYs. The average annual age-standardized incidence rates for all cancers combined increased between 2006 and 2016 for 130 of 195 countries or territories, while the average annual age-standardized death rates decreased in 143 countries or territories.

"Large disparities exist between countries in cancer incidence, deaths, and associated disability," the authors write.

Two authors disclosed financial ties to pharmaceutical and medical technology companies.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Cap'n Crunch Cereal Recalled Due to Salmonella Scare

Cap'n Crunch Cereal Recalled Due to <i>Salmonella</i> Scare

No illnesses related to the products have been reported to date

FDA Approves First-Line Tx for Peripheral T-Cell Lymphoma

FDA Approves First-Line Tx for Peripheral T-Cell Lymphoma

Adcetris approved in combination with chemo to treat systemic anaplastic large cell lymphoma

FDA Warns Against Giving Honey-Filled Pacifiers to Infants

FDA Warns Against Giving Honey-Filled Pacifiers to Infants

Four infants in Texas hospitalized with botulism after using pacifiers containing honey

is free, fast, and customized just for you!




Already a member?

Sign In Now »